Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

Clinical and cell line specific expression profiles of a human gene identified in experimental central nervous system metastases.

Ree AH, Bratland A, Kroes RA, Aasheim HC, Flørenes VA, Moskal JR, Fodstad O, Bruland OS, Maelandsmo GM.

Anticancer Res. 2002 Jul-Aug;22(4):1949-57.

PMID:
12174869
2.

Expression of a novel factor, com1, is regulated by 1,25-dihydroxyvitamin D3 in breast cancer cells.

Bratland A, Risberg K, Maelandsmo GM, Gützkow KB, Olsen OE, Moghaddam A, Wang MY, Hansen CM, Blomhoff HK, Berg JP, Fodstad O, Ree AH.

Cancer Res. 2000 Oct 1;60(19):5578-83.

3.

Expression of a novel factor, com1, in early tumor progression of breast cancer.

Ree AH, Pacheco MM, Tvermyr M, Fodstad O, Brentani MM.

Clin Cancer Res. 2000 May;6(5):1778-83.

4.

Expression of a novel factor in human breast cancer cells with metastatic potential.

Ree AH, Tvermyr M, Engebraaten O, Rooman M, Røsok O, Hovig E, Meza-Zepeda LA, Bruland OS, Fodstad O.

Cancer Res. 1999 Sep 15;59(18):4675-80.

5.

Melanoma-inhibiting activity (MIA/CD-RAP) is expressed in a variety of malignant tumors of mainly neuroectodermal origin.

Hau P, Apfel R, Wiese P, Tschertner I, Blesch A, Bogdahn U.

Anticancer Res. 2002 Mar-Apr;22(2A):577-83.

PMID:
12014625
6.

Differential gene expression of TGF-beta family members and osteopontin in breast tumor tissue: analysis by real-time quantitative PCR.

Reinholz MM, Iturria SJ, Ingle JN, Roche PC.

Breast Cancer Res Treat. 2002 Jun;74(3):255-69.

PMID:
12206515
7.

Suppression of human ovarian carcinoma metastasis by the metastasis-suppressor gene, BRMS1.

Zhang S, Lin QD, DI W.

Int J Gynecol Cancer. 2006 Mar-Apr;16(2):522-31.

PMID:
16681721
8.

Altered subcellular localization and low frequency of mutations of ING1 in human brain tumors.

Vieyra D, Senger DL, Toyama T, Muzik H, Brasher PM, Johnston RN, Riabowol K, Forsyth PA.

Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5952-61. Erratum in: Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):4198. Clin Cancer Res. 2004 May 1;10(9):3233. Toyam, Tatsuya [corrected to Toyama, Tatsuya].

9.

Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.

de Candia P, Akram M, Benezra R, Brogi E.

Hum Pathol. 2006 Aug;37(8):1032-41. Epub 2006 May 22.

PMID:
16867866
11.

Expression analysis of the autosomal recessive primary microcephaly genes MCPH1 (microcephalin) and MCPH5 (ASPM, abnormal spindle-like, microcephaly associated) in human malignant gliomas.

Hagemann C, Anacker J, Gerngras S, Kühnel S, Said HM, Patel R, Kämmerer U, Vordermark D, Roosen K, Vince GH.

Oncol Rep. 2008 Aug;20(2):301-8.

PMID:
18636190
12.

Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.

Huang H, Groth J, Sossey-Alaoui K, Hawthorn L, Beall S, Geradts J.

Clin Cancer Res. 2005 Jun 15;11(12):4357-64.

13.

Hypoxic regulation of PFKFB-3 and PFKFB-4 gene expression in gastric and pancreatic cancer cell lines and expression of PFKFB genes in gastric cancers.

Bobarykina AY, Minchenko DO, Opentanova IL, Moenner M, Caro J, Esumi H, Minchenko OH.

Acta Biochim Pol. 2006;53(4):789-99. Epub 2006 Dec 4.

14.

Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain.

Palmieri D, Bronder JL, Herring JM, Yoneda T, Weil RJ, Stark AM, Kurek R, Vega-Valle E, Feigenbaum L, Halverson D, Vortmeyer AO, Steinberg SM, Aldape K, Steeg PS.

Cancer Res. 2007 May 1;67(9):4190-8.

15.
16.

Oligodendrocyte lineage transcription factor 2 inhibits the motility of a human glial tumor cell line by activating RhoA.

Tabu K, Ohba Y, Suzuki T, Makino Y, Kimura T, Ohnishi A, Sakai M, Watanabe T, Tanaka S, Sawa H.

Mol Cancer Res. 2007 Oct;5(10):1099-109.

17.
18.

Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases.

Stark AM, Tongers K, Maass N, Mehdorn HM, Held-Feindt J.

J Cancer Res Clin Oncol. 2005 Mar;131(3):191-8. Epub 2004 Dec 8.

PMID:
15592684
19.

Supplemental Content

Support Center